Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(2.10) per share which beat the analyst consensus estimate of $(3.16) by 33.54 percent. This is a 65 percent increase over losses of $(6.00) per share from
Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Kintara Therapeutics's (NASDAQ:KTRA) short percent of float has risen 4894.88% since its last report. The company recently reported that it has 2.04 million shares sold short, which is 126.87% of all regular shares that are available for trading.
Major Wall Street indices ended flat on Tuesday as investors and traders shifted their focus to Federal Reserve Chair Jerome Powell’s scheduled speech on Wednesday at an event hosted by the Brookings Institution in Washington.
U.S. stocks traded lower toward the end of trading amid protests over COVID-19 restrictions in China. The Dow Jones dropped more than 450 points on Monday.
Gainers
Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.